Combined treatment with TRAIL and paclitaxel induced apoptosis in 63.4% ± 8.1% of cancer cells in a concentration of 0.25 μM and 65.3% ± 8.7% in a concentration of 0.5 μM in PC3 cells after a 48 h incubation. This evidence concerns the gene TNFSF10 and cancer.